Fredrik Lehmann

Fredrik Lehmann

Born 1976

Member of the board since 2019

Fredrik Lehmann has a PhD in pharmaceutical chemistry and has over 15 years of experience in drug development. Previously, he has worked at Pharmacia, Biovitrum, OT Chemistry and Recipharm, and has founded and operated six companies within Life Science.


M.Sc in Chemistry Uppsala universitet, PhD in Pharmaceutical chemistry Göteborgs Universitet

Other assignments

Head of reseach Oncopeptides, Chairman of the Board Synartro AB, Member of the Board Immuneed, Independent consultant within CMC

Number of shares  (As of  May 11th, 2022)

15 000

Fredrik is independent in relation to the Company and its senior executives as well as independent
in relation to major shareholders.